gms | German Medical Science

83rd Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

16.05. - 20.05.2012, Mainz

Development and Validation of the Frankfurt Dysphagia Screening (FraDySc) for Patients with head and neck cancer after tumor resection First results

Meeting Abstract

Search Medline for

  • corresponding author Christiane Hey - Univ. HNO-Klinik, Frankfurt/M., Germany
  • presenting/speaker Benjamin Lange - Biologische Fakultät inkl. Psychologie, Göttingen, Germany
  • presenting/speaker Silvia Eberle - Univ. HNO-Klinik, Frankfurt/M., Germany
  • presenting/speaker Timo Stöver - Univ. HNO-Klinik, Frankfurt/M., Germany

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. 83rd Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. Mainz, 16.-20.05.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. Doc12hno18

DOI: 10.3205/12hno18, URN: urn:nbn:de:0183-12hno185

Published: July 23, 2012

© 2012 Hey et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Background: Dysphagia is a frequent implication of head and neck cancer (HNC) patients. To date, there is no sufficient screening for swallowing disorders of those patients. Aim of this study is the development and validation of a screening to detect therapy relevant dysphagia of HNC patients after tumor resection.

Methods: The dysphagia screening FraDySc consists of an oromotor testing with a defined water swallow test. FraDySc independently, is tested twice by two therapists followed by a fiberoptic endoscopig evaluation of swallowing (FEES) Langmore-Standard. Since November 2010, 33 HNC patients (Stage II - IV) after tumor resection were documented. Exclusion criteria were a preknown swallowing disorder or neurological diseases. So far, the interraterreliability and the accordance of the Pass/Fail results of FraDySc and FEES were determined.

Results: Up to date the interraterreliability regarding the FraDySc is optimal (Cohen’s κ = 1.00, p < .001) and the concordance of FraDySc and FEES excellent. (Cronbach’s κ = .949).

Conclusion: The first results of this study promise FraDySc as a very good tool for a valid and time efficient identification of patients with a therapy relevant swallowing disorder and therefor the need for an early rehabilitation after tumor resection.